DZ3370A1 - Composes de piperazine et piperidine - Google Patents

Composes de piperazine et piperidine

Info

Publication number
DZ3370A1
DZ3370A1 DZ013370A DZ013370A DZ3370A1 DZ 3370 A1 DZ3370 A1 DZ 3370A1 DZ 013370 A DZ013370 A DZ 013370A DZ 013370 A DZ013370 A DZ 013370A DZ 3370 A1 DZ3370 A1 DZ 3370A1
Authority
DZ
Algeria
Prior art keywords
piperazine
piperidine compounds
piperidine
compounds
Prior art date
Application number
DZ013370A
Other languages
English (en)
French (fr)
Inventor
Roelof W Feenstra
Der Heijden Johannes A M Van
Cornelis G Kruse
Stephen K Long
Scharrenburg Gustaaf J M Van
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Application granted granted Critical
Publication of DZ3370A1 publication Critical patent/DZ3370A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
DZ013370A 2000-05-12 2001-05-10 Composes de piperazine et piperidine DZ3370A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00201699 2000-05-12
PCT/EP2001/005320 WO2001085725A1 (en) 2000-05-12 2001-05-10 Piperazine and piperidine compounds

Publications (1)

Publication Number Publication Date
DZ3370A1 true DZ3370A1 (fr) 2001-11-15

Family

ID=8171488

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ013370A DZ3370A1 (fr) 2000-05-12 2001-05-10 Composes de piperazine et piperidine

Country Status (28)

Country Link
US (2) US6911448B2 (de)
EP (1) EP1283838B1 (de)
JP (1) JP2003532729A (de)
CN (1) CN1174979C (de)
AR (1) AR028443A1 (de)
AT (1) ATE255578T1 (de)
AU (2) AU2001263927B2 (de)
BR (1) BR0110592A (de)
CA (1) CA2405971C (de)
CZ (1) CZ301464B6 (de)
DE (1) DE60101386T2 (de)
DK (1) DK1283838T3 (de)
DZ (1) DZ3370A1 (de)
ES (1) ES2211809T3 (de)
HK (1) HK1055952A1 (de)
HU (1) HUP0302016A2 (de)
IL (2) IL152177A0 (de)
MX (1) MXPA02011084A (de)
NO (1) NO323778B1 (de)
NZ (1) NZ522116A (de)
PL (1) PL198857B1 (de)
PT (1) PT1283838E (de)
RU (1) RU2261250C2 (de)
SK (1) SK286778B6 (de)
TR (1) TR200302294T4 (de)
UA (1) UA72337C2 (de)
WO (1) WO2001085725A1 (de)
ZA (1) ZA200208537B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1174979C (zh) * 2000-05-12 2004-11-10 索尔瓦药物有限公司 哌嗪和哌啶化合物
JP5080716B2 (ja) 2001-07-20 2012-11-21 サイコジェニックス・インコーポレーテッド 注意欠陥・多動性障害の治療
AU2003244160A1 (en) * 2002-06-25 2004-01-06 Sumitomo Pharmaceuticals Co., Ltd. Novel benzoxazolinone derivative
ES2232292B1 (es) * 2003-07-30 2006-11-01 Laboratorios Del Dr. Esteve, S.A. Compuestos sulfonamidicos derivados de benzoxazinona, su preparacion y uso como medicamentos.
EP1595542A1 (de) * 2004-03-26 2005-11-16 Solvay Pharmaceuticals B.V. Transdermale iontophoretische Verabreichung von Piperazinyl-2(3H)-benzoxazolon-Verbindungen
US7596407B2 (en) 2004-03-26 2009-09-29 Solvay Pharmaceuticals, B.V. Transdermal iontophoretic delivery of piperazinyl-2(3H)-benzoxazolone compounds
RU2394821C2 (ru) * 2005-08-22 2010-07-20 Солвей Фармасьютикал Б.В. N-оксиды как пролекарства производных пиперазина и пиперидина
AR058022A1 (es) * 2005-08-22 2008-01-23 Solvay Pharm Bv Derivados de benzooxazoles, composiciones farmaceuticas y su uso para el tratamiento de desordenes del sistema nervioso.
US7750013B2 (en) 2005-08-22 2010-07-06 Solvay Pharmaceuticals, B.V. N-oxides as prodrugs of piperazine and piperidine derivatives
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
MX2009005507A (es) 2006-12-07 2009-06-03 Hoffmann La Roche Derivados de espiro-piperidina.
CN101547923A (zh) 2006-12-07 2009-09-30 弗·哈夫曼-拉罗切有限公司 作为via受体拮抗剂的螺环-哌啶衍生物
ATE527249T1 (de) 2006-12-08 2011-10-15 Hoffmann La Roche Indole
ES2345132T3 (es) 2006-12-08 2010-09-15 F. Hoffmann-La Roche Ag Indoles que actuan como agonistas del receptor v1a.
WO2008077810A2 (en) 2006-12-22 2008-07-03 F. Hoffmann-La Roche Ag Spiro-piperidine derivatives
AU2009204851A1 (en) * 2008-01-15 2009-07-23 Abbott Healthcare Products B.V. Bifeprunox derivatives
US11103499B2 (en) 2016-08-26 2021-08-31 EXCIVA (UG) (haftungsbeschränkt) Compositions and methods thereof
SG11202100680WA (en) * 2018-07-27 2021-02-25 Chugoku Marine Paints Antifouling paint composition, antifouling coating, substrate with antifouling coating, production method thereof, and repair method

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126275A (ja) * 1983-12-13 1985-07-05 Otsuka Pharmaceut Co Ltd ベンゾチアゾ−ル誘導体
FR2567884B1 (fr) * 1984-07-19 1987-03-06 Roussel Uclaf Nouveaux derives de l'indole, leur preparation, leur application comme medicaments et les compositions les renfermant
DE3571436D1 (en) 1984-12-21 1989-08-17 Duphar Int Res New pharmaceutical compositions having anti-psychotic properties
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
CA2250347C (en) 1996-03-29 2006-02-21 Duphar International Research B.V. Piperazine and piperidine compounds with high affinity for dopamine-d2 and serotonin-5ht1a receptors
GB9811879D0 (en) * 1998-06-03 1998-07-29 Knoll Ag Therapeutic agents
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
WO2001085168A1 (en) * 2000-05-12 2001-11-15 Solvay Pharmaceuticals B.V. Use of compounds having combined dopamine d2, 5-ht1a and alpha adrenoreceptor agonistic action for treating cns disorders
CN1174979C (zh) * 2000-05-12 2004-11-10 索尔瓦药物有限公司 哌嗪和哌啶化合物

Also Published As

Publication number Publication date
HK1055952A1 (en) 2004-01-30
WO2001085725A1 (en) 2001-11-15
PT1283838E (pt) 2004-04-30
NO323778B1 (no) 2007-07-02
SK15872002A3 (sk) 2003-04-01
US6911448B2 (en) 2005-06-28
IL152177A (en) 2009-08-03
EP1283838B1 (de) 2003-12-03
US7297699B2 (en) 2007-11-20
SK286778B6 (sk) 2009-05-07
DE60101386D1 (de) 2004-01-15
ES2211809T3 (es) 2004-07-16
PL358201A1 (en) 2004-08-09
DE60101386T2 (de) 2004-05-27
CA2405971A1 (en) 2001-11-15
DK1283838T3 (da) 2004-03-22
CA2405971C (en) 2010-03-30
BR0110592A (pt) 2003-04-01
ZA200208537B (en) 2004-01-22
CZ301464B6 (cs) 2010-03-10
CN1174979C (zh) 2004-11-10
IL152177A0 (en) 2003-05-29
RU2261250C2 (ru) 2005-09-27
AR028443A1 (es) 2003-05-07
CZ20023721A3 (cs) 2003-02-12
NZ522116A (en) 2004-04-30
HUP0302016A2 (hu) 2003-09-29
AU6392701A (en) 2001-11-20
JP2003532729A (ja) 2003-11-05
PL198857B1 (pl) 2008-07-31
NO20025365D0 (no) 2002-11-08
CN1429226A (zh) 2003-07-09
UA72337C2 (uk) 2005-02-15
TR200302294T4 (tr) 2004-02-23
MXPA02011084A (es) 2003-03-10
ATE255578T1 (de) 2003-12-15
US20060089366A1 (en) 2006-04-27
EP1283838A1 (de) 2003-02-19
US20030119849A1 (en) 2003-06-26
NO20025365L (no) 2002-11-08
AU2001263927B2 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
NO20023787D0 (no) Piperazin- og piperidinderivater
AR028343A1 (es) Derivados de pirrolidina y piperidina
DK1325008T3 (da) Piperazinderivater
ATE397595T1 (de) Piperazin-derivate
DE60103472D1 (de) Rohrschneider
NO20026125D0 (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
DZ3370A1 (fr) Composes de piperazine et piperidine
IS6546A (is) Nýjar píperazín afleiður
ATE390099T1 (de) Zwischenwirbelkunststoffimplantat
DK1131308T3 (da) Piperazin- og piperidinderivater
PL355654A1 (en) Piperidine and piperazine derivatives which function as 5-ht2a
ATE321042T1 (de) Piperazin-derivate
NO20023954D0 (no) Substituerte piperasinforbindelser
DE50113112D1 (de) Schaltungsanordnung
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DK1202966T3 (da) Piperidinalkoholer
PT1131308E (pt) Novos compostos de piperazina e piperidina
DE50115426D1 (de) Schaltungsanordnung
FR2814381B1 (fr) Dechiqueteur
DK1037892T3 (da) Piperidinderivater
NO20006505D0 (no) Veske
NO20004021D0 (no) Avfallspose
ATA9272000A (de) Revisionstür
SE0003095D0 (sv) Trash comersiale
SE0004008D0 (sv) Självlåsande gångjärn